Literature DB >> 3209082

New hypotheses on the pathogenesis and treatment of serous retinal detachment.

M F Marmor1.   

Abstract

Recent experimental work has shown that, under normal conditions, most subretinal fluid is absorbed rapidly by active transport across the retinal pigment epithelium (RPE). However, in the presence of damage to the RPE blood-retinal barrier, subretinal fluid is rapidly cleared by passive forces. Thus, it is apparent that RPE defects do not by themselves cause serous retinal detachment. A hypothesis is presented that some serous detachments occur because normal metabolic transport systems of the RPE have been damaged, while the blood-retinal barrier remains intact to prevent passive drainage of the subretinal space. Under these conditions, a focal RPE "leak" can overload the system so that the serous fluid accumulates and persists. Photocoagulation of a leaking point can facilitate resolution of the fluid, but as long as the underlying metabolic dysfunction of the RPE persists, recurrence is possible. Some forms of serous detachment may thus be viewed as diffuse rather than focal ocular disorders in which the transport capability of the RPE has been damaged; such damage can result from systemic pathology such as adrenergic stress (e.g., central serous chorioretinopathy) or vascular disease (e.g., hypertension).

Entities:  

Mesh:

Year:  1988        PMID: 3209082     DOI: 10.1007/bf02169203

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  27 in total

1.  Effects of intraocular pressure and other factors on subretinal fluid resorption.

Authors:  A Negi; S Kawano; M F Marmor
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-12       Impact factor: 4.799

2.  The treatment of retinal detachment without drainage of subretinal fluid. (Modifications of the Custodis procedure. VI).

Authors:  H Lincoff; I Kreissig
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1972 Sep-Oct

3.  Some aspects of the ocular circulation. Friedenwald lecture.

Authors:  A Bill
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-04       Impact factor: 4.799

4.  The rate and route of fluid resorption from the subretinal space of the rabbit.

Authors:  D A Frambach; M F Marmor
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-03       Impact factor: 4.799

5.  The EOG and choroidal malignant melanomas.

Authors:  J A Staman; C R Fitzgerald; W W Dawson; M C Barris; C I Hood
Journal:  Doc Ophthalmol       Date:  1980-10-15       Impact factor: 2.379

6.  Experimental serous retinal detachment and focal pigment epithelial damage.

Authors:  A Negi; M F Marmor
Journal:  Arch Ophthalmol       Date:  1984-03

7.  Diabetic maculopathy. A critical review highlighting diffuse macular edema.

Authors:  G H Bresnick
Journal:  Ophthalmology       Date:  1983-11       Impact factor: 12.079

8.  Central serous chorioretinopathy: some considerations on the pathogenesis.

Authors:  F C Piccolino
Journal:  Ophthalmologica       Date:  1981       Impact factor: 3.250

9.  Pharmacologic modification of subretinal fluid absorption in the rabbit eye.

Authors:  M F Marmor; A Negi
Journal:  Arch Ophthalmol       Date:  1986-11

10.  Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings.

Authors:  H Yoshioka; Y Katsume; H Akune
Journal:  Ophthalmologica       Date:  1982       Impact factor: 3.250

View more
  32 in total

Review 1.  Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.

Authors:  E Zamir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

2.  Alcohol- and light-induced electro-oculographic responses in age-related macular degeneration & central serous chorioretinopathy. alcohol- and light-induced EOG responses in ARMD & CSC.

Authors:  Kathy H C Wu; Michael F Marmor
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

3.  Pattern ERG in central serous retinopathy.

Authors:  Jawahar Lal Goyal; Basudeb Ghosh; Vishram Sangit; Sushil Kumar; Parul Jain; Vikas Veerwal; Ritu Arora
Journal:  Doc Ophthalmol       Date:  2014-12-27       Impact factor: 2.379

4.  Macular detachment following laser treatment for proliferative diabetic retinopathy.

Authors:  A Elliott; D Flanagan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

5.  Smokestack leak in central serous chorioretinopathy.

Authors:  Dhiren Bujarborua; Pran N Nagpal; Manab Deka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-15       Impact factor: 3.117

6.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors:  W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

7.  Features of abnormal choroidal circulation in central serous chorioretinopathy.

Authors:  N Kitaya; T Nagaoka; T Hikichi; R Sugawara; K Fukui; S Ishiko; A Yoshida
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

8.  A new therapeutical approach to central serous retinopathy, a hypothesis.

Authors:  F Rathschuler; S Lai; D Ghiglione; P Rossi; G Ciurlo
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

9.  Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy.

Authors:  F Ricci; F Missiroli; F Regine; M Grossi; G Dorin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-17       Impact factor: 3.117

10.  Indocyanine green angiographic findings in central serous chorioretinopathy.

Authors:  C Prünte
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.